WARNER C. GREENE, M.D.; WARREN J. LEONARD, M.D.; JOEL M. DEPPER, M.D.; DAVID L. NELSON, M.D.; THOMAS A. WALDMANN, M.D.
The human receptor for interleukin-2 (T-cell growth factor) plays a critical role in the growth of T cells and is required for full expression of the normal immune response. Through hybridoma and recombinant DNA techniques, the interleukin-2 receptor protein has been biochemically characterized and purified; full-length copies of its complementary DNA have been molecularly cloned, sequenced, and expressed in eukaryotic cells; and the receptor gene has been characterized. Transient expression of the interleukin-2 receptor gene occurs during normal T-cell activation, and high- and low-affinity forms of the membrane receptor exist. A naturally occurring, soluble receptor has also been isolated, and its levels in serum correlate with the activity of various diseases. Deregulation of interleukin-2 receptor expression occurs in T-cell leukemias produced by the human T-lymphotropic retroviruses types l and ll (HTLV-l and -ll) and has been causally linked to the action of the trans-activator (tat) gene of these viruses. Monoclonal antibodies specific for the interleukin-2 receptor are being evaluated in the treatment of HTLV-l-induced leukemias and other conditions involving the inappropriate function of activated T cells.
GREENE WC, LEONARD WJ, DEPPER JM, NELSON DL, WALDMANN TA. The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic Retroviruses. Ann Intern Med. ;105:560–572. doi: 10.7326/0003-4819-105-4-560
Download citation file:
Published: Ann Intern Med. 1986;105(4):560-572.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use